Related references
Note: Only part of the references are listed.Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy The EMERALD Study
Noemi Lois et al.
OPHTHALMOLOGY (2021)
Treatment Patterns for Diabetic Macular Edema: An Intelligent Research in Sight (IRIS®) Registry Analysis
Ronald A. Cantrell et al.
OPHTHALMOLOGY (2020)
Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Antie-Vascular Endothelial Growth Factor
Anthony Obeid et al.
OPHTHALMOLOGY (2019)
Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions
Thomas J. Wubben et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD)
Noemi Lois et al.
BMJ OPEN (2019)
Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy
Charles C. Wykoff et al.
OPHTHALMOLOGY RETINA (2018)
Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome
B. Foot et al.
EYE (2017)
Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014
Rohini Mathur et al.
BMJ OPEN (2017)
Share Paper
